Over the past 12 months, 2 insiders at Adicet Bio, Inc. filed 9 open-market SEC Form 4 transactions on ACET: 5 purchases worth $6.6M and 4 sales worth $675K. Insiders have been mixed over this period. The most recent filing was on Apr 8, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 8, 26 | Orbimed Advisors Llc | SELL | 40.4K | $6.52 | $264K |
| Apr 7, 26 | Orbimed Advisors Llc | SELL | 29.3K | $6.53 | $191K |
| Feb 20, 26 | Ra Capital Management, L.p. | BUY | 74.8K | $7.27 | $543K |
| Feb 19, 26 | Ra Capital Management, L.p. | BUY | 74.3K | $7.21 | $535K |
| Feb 18, 26 | Ra Capital Management, L.p. | BUY | 74.6K | $7.04 | $525K |
| Oct 8, 25 | Orbimed Advisors LlcTenPercentOwner | BUY | 3.50M | $1.00 | $3.5M |
| Jun 5, 24 | Michael KauffmanDirector | SELL | 5.9K | $1.43 | $8K |
| Jan 25, 24 | Carl L GordonDirector,TenPercentOwner | BUY | 1.84M | $2.40 | $4.4M |
| Jan 25, 24 | Orbimed Advisors Israel II LtdDirector,TenPercentOwner | BUY | 1.84M | $2.40 | $4.4M |
| Oct 2, 23 | Chen SchorPresident & CEO | BUY | 5.5K | $1.33 | $7K |
| Sep 29, 23 | Chen SchorPresident & CEO | SELL | 5.5K | $1.36 | $7K |
| Sep 28, 23 | Chen SchorPresident & CEO | BUY | 5.5K | $1.42 | $8K |
| Sep 28, 23 | Chen SchorPresident & CEO | SELL | 5.5K | $1.42 | $8K |
| Jun 30, 23 | Steve DubinDirector | BUY | 5.0K | $2.40 | $12K |
| Jun 27, 23 | Carl L GordonDirector,TenPercentOwner | BUY | 442.0K | $2.09 | $924K |
| Jun 27, 23 | Orbimed Advisors LlcDirector,TenPercentOwner | BUY | 442.0K | $2.09 | $924K |
| Feb 15, 23 | Don HealeyChief Technology Officer | SELL | 4.5K | $7.57 | $34K |
| Feb 10, 23 | Don HealeyChief Technology Officer | SELL | 10.5K | $7.98 | $84K |
| Nov 10, 22 | Blake AftabChief Scientific Officer | SELL | 7.0K | $21.00 | $146K |
| Nov 10, 22 | Chen SchorPresident & CEO | SELL | 30.0K | $21.03 | $602K |
| Nov 7, 22 | Chen SchorPresident & CEO | SELL | 30.0K | $19.05 | $572K |
| Nov 3, 22 | Chen SchorPresident & CEO | SELL | 24.8K | $18.04 | $448K |
| Nov 2, 22 | Chen SchorPresident & CEO | SELL | 500 | $18.00 | $9K |
| Oct 19, 22 | Blake AftabChief Scientific Officer | SELL | 8.1K | $16.27 | $131K |
| Oct 12, 22 | Blake AftabChief Scientific Officer | SELL | 1.6K | $15.40 | $25K |
| Sep 14, 22 | Chen SchorPresident & CEO | SELL | 952 | $18.00 | $17K |
| Sep 13, 22 | UnknownPresident & CEO | SELL | 3.4K | $18.01 | $61K |
| Sep 12, 22 | UnknownPresident & CEO | SELL | 66.7K | $18.00 | $1.1M |
| Sep 9, 22 | UnknownPresident & CEO | SELL | 8.1K | $16.51 | $134K |
| Aug 3, 22 | Blake AftabChief Scientific Officer | SELL | 7.0K | $18.00 | $125K |
| Aug 1, 22 | Blake AftabChief Scientific Officer | SELL | 7.0K | $16.64 | $116K |
| Jul 5, 22 | Blake AftabChief Scientific Officer | SELL | 1.4K | $14.50 | $20K |
| Apr 4, 22 | Francesco GalimiSVP & Chief Medical Officer | SELL | 6.0K | $21.00 | $127K |
| Apr 1, 22 | Francesco GalimiSVP & Chief Medical Officer | SELL | 7.6K | $21.00 | $160K |
| Mar 9, 22 | Aya JakobovitsDirector | SELL | 2.0K | $14.00 | $28K |
| Feb 16, 22 | Aya JakobovitsDirector | SELL | 2.0K | $14.83 | $30K |
| Feb 9, 22 | Aya JakobovitsDirector | SELL | 4.0K | $14.03 | $56K |
| Jan 5, 22 | Aya JakobovitsDirector | SELL | 2.0K | $16.93 | $34K |
| Jan 3, 22 | Aya JakobovitsDirector | SELL | 6.0K | $18.02 | $108K |
| Dec 22, 21 | Aya JakobovitsDirector | SELL | 7.0K | $16.02 | $112K |
| Dec 8, 21 | Andrew SinclairDirector | BUY | 500.0K | $14.00 | $7.0M |
Over the past 12 months, insiders at Adicet Bio, Inc. filed 5 open-market purchases worth $6.6M and 4 sales worth $675K on ACET, which makes them mixed over the period. The most recent Form 4 was filed on Apr 8, 26.
The largest recent open-market ACET insider purchase in our data was $7.0M by Andrew Sinclair, Director, filed on Dec 8, 21.
2 different insiders at Adicet Bio, Inc. filed open-market SEC Form 4 transactions on ACET over the last 12 months.
InsiderTape plots every ACET insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Adicet Bio, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →